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A universal primer-independent 
next-generation sequencing 
approach for investigations of 
norovirus outbreaks and novel 
variants
Jannik Fonager1, Marc Stegger2, Lasse Dam Rasmussen1, Mille Weismann Poulsen1, Jesper 
Rønn1, Paal Skytt Andersen  2,4 & Thea Kølsen Fischer1,3
Norovirus (NoV) is the most common cause of non-bacterial gastroenteritis and is a major agent 
associated with outbreaks of gastroenteritis. Conventional molecular genotyping analysis of NoV, 
used for the identification of transmission routes, relies on standard typing methods (STM) by Sanger-
sequencing of only a limited part of the NoV genome, which could lead to wrong conclusions. Here, 
we combined a NoV capture method with next generation sequencing (NGS), which increased the 
proportion of norovirus reads by ~40 fold compared to NGS without prior capture. Of 15 NoV samples 
from 6 single-genotype outbreaks, near full-genome coverage (>90%) was obtained from 9 samples. 
Fourteen polymerase (RdRp) and 15 capsid (cap) genotypes were identified compared to 12 and 13 for 
the STM, respectively. Analysis of 9 samples from two mixed-genotype outbreaks identified 6 RdRp and 
6 cap genotypes (two at >90% NoV genome coverage) compared to 4 and 2 for the STM, respectively. 
Furthermore, complete or partial sequences from the P2 hypervariable region were obtained from 7 
of 8 outbreaks and a new NoV recombinant was identified. This approach could therefore strengthen 
outbreak investigations and could be applied to other important viruses in stool samples such as 
hepatitis A and enterovirus.
Norovirus (NoV) is a positive-sense single-stranded RNA virus in the Caliciviridae family, and at least 40 gen-
otypes divided into seven genogroups have been identified1–3. NoV infection is the most widespread cause of 
non-bacterial gastroenteritis, responsible for up to one fifth of all cases of gastroenteritis globally4. Despite some 
progress5, 6, no vaccine or therapeutic intervention is available, and interceptive strategies mainly aim to rap-
idly identify the source of infection, increase hygiene measures, and isolate infected patients7, 8. Conventional 
molecular analysis of NoV transmission routes relies mainly on standard typing methods (STM) based on 
Sanger-sequencing of partial RNA-dependent polymerase and capsid genes (RdRp and cap)9, 10. More recently, 
sequencing of larger parts of the capsid gene containing the hypervariable P2 region has increased the discrim-
inatory power to resolve outbreaks with higher accuracy11, 12. Although new recombinant or dominant NoV 
strains has routinely been reported13, 14, commonly used gene-specific primers may have limited the ability to 
rapidly detect emerging strains due to sequence differences in the primer binding regions. In such situations, it is 
necessary to amplify and sequence these regions using other primers and subsequently to make these sequences 
publically available to enable other research groups to redesign their primers accordingly. Therefore, the cur-
rent STM for analysis could lead to incorrect conclusions about possible transmission chains, underestimation 
of the genetic diversity of NoV, and delay early identification of new emerging strains. Recent methodologi-
cal approaches including NGS to achieve full norovirus genome coverage have been published. However, these 
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methods mostly rely on genotype specific primers15–17 why they, are time consuming and need frequent updating 
due to the high natural mutation rates of NoV18.
Cultivation of pathogens is commonly used to ensure a pure and high concentration for further investigation 
and has combined with NGS considerably improved the ability to identify transmission chains and resistance 
genes for cultivated bacterial infections in particular19, 20. Although human NoV to some degree can replicate in 
animal models, no cell culture system exists21. Therefore investigation of NoV suspected cases is usually limited 
to direct analysis of viral RNA in stool samples, in which viral genomes only constitute a minor proportion of the 
nucleic acids present22–24.
Recent studies have addressed several of these problems by using both random sequencing24, 25 strategies and 
different methods for virus enrichment such as: virion isolation and enzymatic removal of host/bacterial nucleic 
acids26, capture-based27–29 methods or PCR activated cell-sorting methods30. Despite these recent advances, such 
methods are still time-consuming, laborious and potentially costly and/or rely on approaches that will require 
extensive periodic updates in primers or probes to reflect the current knowledge on viral diversity.
In this study, we have evaluated an easy-to-use laboratory method that allows for a ~40-fold enrichment of 
all NoV genotypes in stool samples. Furthermore, we have used bioinformatics approaches to accurately screen 
for NoV in highly complex samples. Analysis of NoV positive samples from eight foodborne outbreaks yielded 
sufficient NoV read counts to allow the assembly of several complete or nearly complete genomes for molecular 
comparisons. Furthermore, this approach allowed for the identification of an additional genotype, missed by 
STM, as well as discovery of a new recombinant NoV.
Results
Using NGS directly on samples. Despite a large sequencing depth allocated to each sample (1.5 to 5.5 
million reads), only a relatively small proportion of the obtained reads were of NoV origin (on average: 0.25%; 
corresponding to ~700 to ~22,000 reads).
Evaluation of the poly(A)-capture technique. To specifically enrich for NoV RNA and reduce the 
amount of non-polyadenylated bacterial RNA, a poly(A)-capture method was employed after nucleic acid extrac-
tion. To evaluate this enrichment strategy, NoV viral load was measured in 6 GGI and 3 GGII quantitated survey 
samples were (called QS1 to QS9, See Materials and methods and Table 1) along with five non-quantified survey 
samples (called S1 to S5, See Table 1 and Materials and Methods). All samples were split after RNA extraction 
with only one part subjected to poly(A)-capture. SMARTer libraries were constructed from both extracted parts 
and subjected to MiSeq sequencing simultaneously. The efficiency (Table 1) was evaluated by measuring the pro-
portion of reads mapping to full genome sequences from the common human gut bacterial species Bacterioides 
uniformis and Ruminococcus bromii L2 + 6331 or from a set of 16 sRNA sequences identified in human microbi-
ome studies32, 33. Poly(A)-capture increased the proportion of obtained NoV reads over the entire range of NoV 
input RNA copies (Log10 1,89 to 6,82; see Table 1 and Fig. 1), despite some variation for especially samples with 
low numbers of input NoV RNA copies. While the proportion of bacterial reads was reduced by 0.28 to 0.41 fold, 
the number of NoV reads increased by on average 45.1 ± 27.77 -fold. Although the average Ct value decreased by 
0.96 ± 0.07-fold after poly(A)-capture, the poly(A)-captured NoV was also eluted in only one fifth of the suspen-
sion volume used before poly(A)-capture. The average percentages of reads from the non poly(A)-captured sur-
vey samples mapping to three approximately equally- sized parts of the NoV reference genome sequences were: 
1st part (genome-position: 1–2499): 32.2% (±17.7%), 2nd part (genome-position: 2500–4997): 53.3% (±12.8%) 
and 3rd part (genome-position: 4998–7496): 14.5% (±8.9%), while the average percentages of NoV reads from the 
poly(A)-captured survey samples mapping to these regions were: 1st part: 10.1% (±3.2%), 2nd part: 43.5% (±8%) 
and 3rd part: 46.4% (±8.9%).
Outbreak analysis. Samples from all eight outbreaks were subjected to the poly(A)-capture method and 
SMARTer library construction. A general linear trend was observed between the Ct values measured after 
poly(A)-capture and the number of reads obtained (Fig. 2), although a few samples deviated from this trend 
by containing a higher than expected number of NoV reads per million reads. Although full-genome coverage 
(>99%) was observed at ~4,800 NoV reads in total, equivalent to an average coverage of ~80 per sample (Fig. 3), 
sufficient sequence quality along the entire genome was only observed above ~11,000 reads with an average cov-
erage of ~260.
Assigning genotypes to outbreak samples. The first level of sequence comparison in an outbreak is the 
comparison of genotypes obtained from different persons in the outbreak. Complete NoV genotyping relies on 
sufficient sequence coverage in two regions: ORF1 (RdBp/pol) and ORF2 (Cap) for complete genotyping. Using 
the NGS approach, 14 complete and one partial genotype were detected in 15 samples from 6 of the 8 outbreaks 
(see Table 2) containing a single NoV genotype compared with 10 complete and five partial genotypes detected 
with the STM approach.
Since it had been demonstrated by Real time PCR and STM that two NoV genogroups and several genotypes 
were involved in Ob-4 and Ob-6, HMM searches for additional genotypes was performed on de novo assembled 
contigs (See Materials and Methods). From sample Ob-4-1, 10,765 and from sample Ob-4-2 15,391 de novo 
assemblies were generated, of which 11 and 107 were identified as norovirus assemblies by the HMM search 
respectively. The candidate NoV contigs were further investigated by BLASTN and genotyping of the contigs, 
with subsequent reference based mapping which confirmed the presence of the following genotypes in the two 
samples: Ob-4-1: GII.Pg_GII.1 and GII.4_Sydney, Ob-4-2: GI.Pb_GI.6 and GII.7P_GII.6 (Table 2). Due to insuf-
ficient reads mapping to the GI.Pb_GI.6 reference in sample Ob-4-1, a valid phylogenetic comparison could not 
be performed, although a BLASTN of the consensus sequence generated from the 22 mapped reads indicated this 
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to be GI.Pb_GI.6 as well. The HMM analysis also detected genotype GII.Pg_GII.1 in the Ob-4-1 sample which 
was not identified by STM.
From Outbreak 6, the following numbers of HMM hits were obtained out of the total number of de novo 
assembled contigs: Ob-6-1: 0 of 18,361, Ob-6-2: 2 of 1,928, Ob-6-3: 11 of 18,973, Ob-6-4: 6 of 34,959, Ob-6-5: 5 of 
37,507, Ob-6-6: 4 of 14,250 and Ob-6-7: 1 of 43,308. Following the same procedure as described for Ob-4 lead to 
the identification of GII.P7_GII.6 and GI.P3_GI.3 in all seven samples. The GII.P7_GII.6 genotype was supported 
by a large number of reads in all samples except Ob-6-3 and could be compared phylogenetically, whereas the 
GI.P3_GI.3 genotype was only supported by a low number of reads in all samples. This also suggested that the two 
NoV genotypes were present in all the samples at variable concentrations.
Overall, support for the hypothesis of a common infection source by shared pol and cap genotypes for at least 
one genotype and in at least two different persons from the outbreak was obtained for seven of eight outbreaks 
with the NGS method and for five of eight outbreaks with the STM method. Similar genotypes were observed in 
Sample name Genotype
Input NoV 
genome 
copies 
(Log10 
RNA)
Ct 
value
Reads in 
total
Reads after 
QC and 
trim
NoV 
mappings
Norovirus 
reads/
million
B.
uniformis 
reads/
million
R. bromii 
reads/
million
16 sRNA 
reads/
million
S1
GII.P21_GII.3 ND
24.54 2,496,612 2,374,862 740 312 255,100 448,900 39,900
S1-poly (A) 23.72 757,000 546,555 7,900 14,454 96,400 173,800 12,400
S2
GI.P3_GI.3 ND
26.3 6,353,762 5,609,338 15,392 2,744 211,200 185,900 90,500
S2-poly (A) 23.96 3,257,730 2,000,579 467,920 233,892 28,600 22,500 7,800
S3
GII.P2_GII.2 ND
24.93 1,572,564 1,555,059 5,969 3,838 530,700 377,500 140,600
S3-poly (A) 21.18 5,260,882 3,233,749 742,233 229,527 202,700 170,500 50,300
S4
GI.Pb_GI.6 ND
26.31 6,034,124 5,659,453 22,362 3,951 192,800 142,600 42,100
S4-poly (A) 23.72 4,037,036 1,992,270 579,005 290,626 97,500 77,900 18,700
S5
GII.P4_New_Orleans_GII.4_Sydney ND
27.8 2,818,760 2,818,760 15 5 101,800 20,800 5,900
S5-poly (A) 28.04 2,291,272 2,291,247 567 247 13,600 2,100 500
QS1
GI.P2_GI.2 4.52
28 1,156,547 1,100,750 221 201 306,622 438,377 88,697
QS1-poly(A) 27.21 198,236 168,378 1,085 6,444 108,328 200,127 32,635
QS2
GI.P2_GI.2 4.32
28.57 455,397 429,594 328 764 169,900 175,016 35,056
QS2-poly(A) 30.03 113,549 81,662 331 4,053 34,373 42,578 6,392
QS3
GI.P2_GI.2 3.44
31.25 600,614 556,485 1,118 2,009 196,652 341,026 73,608
QS3-poly(A) 28.81 142,905 106,593 1,289 12,093 39,487 51,551 10,770
QS4
GI.P2_GI.2 3.31
31.74 1,492,849 1,381,510 4 3 492,752 298,984 94,092
QS4-poly(A) 35.18 543,183 508,218 10 20 388,874 279,274 70,013
QS5
GI.P2_GI.2 1.89
36 909,479 852,574 6 7 442,575 78,369 29,316
QS5-poly(A) 32.57 171,507 143,530 69 481 179,419 24,838 5,093
QS6
GI.P2_GI.2 6.82
20.97 2,010,472 1,806,439 6,595 3,651 166,246 53,235 25,712
QS6-poly(A) 20.36 385,509 329,523 30,003 91,050 25,889 11,247 4,085
QS7
GII.P16_GII.2 5.34
21.64 3,959,850 3,484,988 3,117 894 398,987 29,031 93,143
QS7-poly(A) 19.03 765,614 560,343 39,653 70,766 44,687 34,522 7,281
QS8
GII.P16_GII.2 6.14
19.2 1,433,289 1,263,790 4,406 3,486 328,972 389,494 113,065
QS8-poly(A) 19.83 655,710 515,093 59,216 114,962 143,494 184,035 80,587
QS9
GII.P16_GII.2 5.20
22.07 2,846,076 2,734,410 1,975 722 458,107 157,780 72,029
QS9-poly(A) 21.28 354,398 284,150 13,302 46,813 38,054 20,419 4,832
Average fold change NR NR 0.96 NR NR NR 45.13 0.31 0.41 0.28
Standard deviation NR NR 0.07 NR NR NR 27.77 0.20 0.32 0.23
Table 1. Summary of quantification, sequencing, mapping and genotyping results of outbreak samples before 
and after poly(A)-capture. Legend: Column 1: Sample name (S: Survey sample, QS: Quantitative Survey 
sample, data for the sample both before and after poly(A) capture is shown), Column 2: Genotype identified 
in the sample by STM and used here as a reference sequence, Column 3: Total number of input NoV RNA 
copies (log10) used as input to poly(A) capture and library construction, Column 4: Ct value, Column 5: Total 
number of reads obtained before QC and trimming, Column 6: Total number of reads after quality trimming 
and filtering, Column 7: Number of NoV reads mapped to reference sequence indicated in Column 2, Column 
8: NoV reads expressed per million reads in total, Column 9: NoV reads expressed per million reads in total, 
Column 10: B.uniformis reads expressed per million reads in total, Column 11: R. bromii uniformis reads 
expressed per million reads in total, Column 12: 16 sRNA reads expressed per million reads in total. The two 
rows at the bottom of the figure shows the calculated average fold change and standard deviation for all relevant 
measurements before and after poly(A) capture. ND: No data. NR: Not relevant.
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several of the outbreaks, all of which were found to be different (identities: Ob-1/Ob-6: 84.4%, Ob-2/Ob-3: 99.8%, 
Ob-4/Ob-6: 84.2%, Ob-4/Ob-7/S-4: 97.6% to 98.8%, S-5/Ob-5: 97.3%).
Phylogenetic analysis of outbreak samples. Phylogenetic analysis was performed for all outbreaks, 
except for Ob-4 due to the absence of shared well-covered genotype reference sequences. Consensus sequences 
with the following maximum lengths were generated in CLCbio: Ob-1: 7666 nt, Ob-2: 1828 nt, Ob-3: 1226 nt, 
Ob-4: not analyzed, Ob-5: 1593 nt, Ob-6:7344 nt, Ob-7: 7697 nt, Ob-8: 6228 nt and used in a phylogenetic com-
parison. The genome coverage is shown in Fig. 4 for the individual outbreaks. The comparison included either the 
complete hypervariable P2 region (P2 region is 456 to 483 nt depending on genotype) for Ob-1, Ob-6, Ob-7 and 
Ob-8, and partial P2 region comparisons for Ob-2 (471 nt), Ob-3 (243 nt) and Ob-5 (291 nt). The phylogenetic 
analysis revealed that the NoV involved in Ob-3, Ob-5 and Ob-7 were 100% identical (Fig. 4f,h and l), whereas 
Figure 1. Relationship between the number of NoV RNA copies used as input and the obtained number of 
NoV reads before and after poly(A) capture NoV input was quantified with real time PCR and GGI and GGI 
standards and the total number of NoV genome copies used as input was calculated as NoV RNA copies (log10) 
and shown on the X-axis. The number of NoV reads obtained per million reads is shown on the Y axis (log10 
scale). For each sample, the obtained NoV reads per million reads are shown both with poly(A) capture (filled 
squares) and without poly(A) capture (filled circles).
Figure 2. Relationship between Ct value (x axis) and the number of NoV reads per million reads (y axis, Log10). 
A robust regression analysis was performed in Prism (Robust Sum of Squares: 36.72).
Figure 3. Relationship between the log10 number of NoV reads (X axis) and the percentage of full-genome 
coverage (Y axis: solid line) and the average read depth (Y axis: dotted line).
www.nature.com/scientificreports/
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differences in the NoV genomes (Fig. 4b,d,j and o) were observed for: Ob-1 (1 nt difference; two samples had an 
A-residue at reference sequence position 3321 while three samples had a G-residue), Ob-2 (3 nt differences in the 
P2 region), Ob-6 (1 nt difference in ORF3 and several differences in the 3′ non-coding A rich part of the genome), 
Ob-8 (1 nt difference in the P2 region).
Identifying a new recombinant. When reads from the two samples from Ob-8 were mapped to the two 
reference sequences known to be present from the initial partial genotyping, a mutually exclusive distribution 
of reads was observed (Fig. 5a and b). In addition, reads that spanned the ORF1/ORF2 junction of an in silico 
Sample 
name
Reads in 
total
Reads after 
QC/trim Reference (genotype/acc. nr.)
Mapped 
reads
NGS-Pol/
Capsid
Sanger Pol/
Capsid
Average 
coverage
% of genome 
at any/quality 
depth
ob1-1 2,817,260 1,799,640 GI.P3_GI.3 (de novo) 778,531 +/+ −/+ 15,617,24 100/100
ob1-2 2,663,142 1,855,781 GI.P3_GI.3 (de novo) 392,993 +/+ +/+ 7,621,52 100/100
ob1-3 3,219,366 1,229,819 GI.P3_GI.3 (de novo) 102,072 +/+ +/+ 1,985,00 100/99.97
ob1-4 3,548,472 1,259,481 GI.P3_GI.3 (de novo) 48,832 +/+ +/− 953,25 100/99.97
ob1-5 2,935,372 1,553,556 GI.P3_GI.3 (de novo) 13,242 +/+ +/− 260,26 100/99.66
ob2-1 6,127,782 2,586,676 GII.P21_GII.3 (KM198484) 1,807 +/+ +/+ 35,78 89/69.21
ob2-2 2,524,586 1,138,380 GII.P21_GII.3 (KM198484) 213 +/+ +/+ 4.51 60/24.62
ob3-1 2,696,616 1,316,156 GII.P21_GII.3 (EU921389) 235 +/+ +/+ 4.58 45/23.27
ob3-2 2,685,158 1,516,777 GII.P21_GII.3 (EU921389) 231 −/+ +/+ 4.27 47/22.47
ob4-1a 1,911,857 953,505 GII.P7_GII.6 (KM198534) 0 −/− +/− 0 0/0
ob4-2a 3,100,594 1,596,062 GII.P7_GII.6 (KM198534) 3,811 +/+ −/− 74.06 89/68.57
ob4-1b 1,911,857 953,505 GII.Pe_GII.4_Sydney (JX459908) 48 +/+ +/− 0.95 41/3.36
ob4-2b 3,100,594 1,596,062 GII.Pe_GII.4_Sydney (JX459908) 0 −/− −/− 0 0/0
ob4-1c 1,911,857 953,505 GII.Pg_GII.1 (HCU07611) 56 +/+ −/− 1.33 35/4.65
ob4-2c 3,100,594 1,596,062 GII.Pg_GII.1 (HCU07611) 0 −/− −/− 0 0/0
ob4-1d 1,911,857 953,505 GI.Pb_GI.6 (JQ388274) 22 −/− +/− 0.27 18/0
ob4-2d 3,100,594 1,596,062 GI.Pb_GI.6 (JQ388274) 35,464 +/+ −/− 682.34 100/97.37
ob5-1 2,911,740 2,830,406 GII.P4_New_Orleans_GII.4_Sydney (KJ685411) 191 +/+ +/+ 3.52 75/21.8
ob5-2 2,652,197 2,554,030 GII.P4_New_Orleans_GII.4_Sydney (KJ685411) 11,523 +/+ +/+ 263.01 100/99.6
Ob6-1a 4,777,166 4,448,206 GII.P7_GII.6 (de novo) 3,043 +/+ +/− 48.79 99/97.59
Ob6-2a 5,480,180 4,999,737 GII.P7_GII.6 (de novo) 4,849 +/+ +/− 85.45 99/93.58
Ob6-3a 5,530,180 5,148,480 GII.P7_GII.6 (de novo) 568 −/+ −/+ 2.74 47/3.15
Ob6-4a 6,190,156 5,800,357 GII.P7_GII.6 (de novo) 1,705 +/+ −/+ 26.75 99/93.55
Ob6-5a 5,126,044 4,097,985 GII.P7_GII.6 (de novo) 4,152 +/+ +/− 81.7 93/84.5
Ob6-6a 3,665,052 3,470,936 GII.P7_GII.6 (de novo) 1,713 +/+ −/− 27.18 89/74.16
Ob6-7a 8,212,260 5,991,822 GII.P7_GII.6 (de novo) 62,140 +/+ −/− 1,163.98 100/99.97
Ob6-1b 4,777,166 4,448,206 GI.P3_GI.3 (KJ196292.1) 116 −/+ −/− 0.28 12/0.52
Ob6-2b 5,480,180 4,999,737 GI.P3_GI.3 (KJ196292.1) 99 −/− −/+ 0.26 9/0.96
Ob6-3b 5,530,180 5,148,480 GI.P3_GI.3 (KJ196292.1) 968 +/+ −/+ 15.68 88/61.56
Ob6-4b 6,190,156 5,800,357 GI.P3_GI.3 (KJ196292.1) 76 −/+ −/+ 0.23 12/0.21
Ob6-5b 5,126,044 4,097,985 GI.P3_GI.3 (KJ196292.1) 37 −/+ −/− 0.13 7/0
Ob6-6b 3,665,052 3,470,936 GI.P3_GI.3 (KJ196292.1) 84 −/− −/− 0.21 9/0.52
Ob6-7b 8,212,260 5,991,822 GI.P3_GI.3 (KJ196292.1) 292 −/+ −/− 1.06 14/1.92
Ob7-1 4,313,560 3,815,832 GI.Pb_GI.6 (JQ388274) 1,190,234 +/+ +/+ 29,108.99 100/100
Ob7-2 5,597,036 5,525,067 GI.Pb_GI.6 (JQ388274) 2,797,949 +/+ +/+ 72,731.53 100/100
Ob8-1 457,494 417,360 GII.P16_GII.4_Sydney (de novo) 1,514 +/+ −/+ 38.76 93.88/86.21
Ob8-2 2,387,298 2,103,897 GII.P16_GII.4_Sydney (de novo) 2,673 +/+ −/+ 67.22 97.81/90.46
Table 2. Summary of sequencing, mapping and genotyping results of outbreak samples. Legend: Column 1: 
Sample name. Samples with identical numbers but different letters at the end are identical, but were mapped to 
different genotype reference sequence., Column 2: Total number of reads obtained before QC and trimming, 
Column 3: Total number of reads after quality trimming and filtering, Column 4: Genotype of NoV reference 
sequence used for mapping, Column 5: Number of reads mapped to reference sequence indicated in Column 4, 
Column 6: Pol or capsid genotyping results obtained with the NGS approach (genotype obtained: +, genotype 
not obtained: −), Column 7: Pol or capsid genotyping results obtained with the Sanger approach, Column 
8: Percentage of reference sequence covered at either any fold coverage (to the left of the slash) or at >2 fold 
coverage (to the right of the slash). Consensus sequences generated from the >2 fold coverage were used for 
phylogenetic analysis. ND: No data.
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Figure 4. Genome coverage and phylogenetic comparison. Genome coverages are shown on the left side of the 
figure for the following outbreaks: Ob-1 (a), Ob-2 (c), Ob-3 (e), Ob-5 (g), Ob-6 (i), Ob-7 (l) and Ob-8 (m and 
n). The range of reads in the coverage plots are shown to the left of each coverage plot and the position on the 
used reference sequence is shown on the top. Phylogenetic trees of the consensus sequences are shown on the 
right side of the figure for the following outbreaks: from Ob-1 (b), Ob-2 (d), Ob-3 (f), Ob-5 (h), Ob-6 (j), Ob-7 
(l) and Ob-8 (o) and relevant reference sequences.
www.nature.com/scientificreports/
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generated reference sequence were observed (Fig. 5c), confirming that both these samples harbored a novel GII.
P16_GII.4_Sydney recombinant.
Discussion
The use of poly(A)-capture significantly enhanced the number of norovirus reads obtained from stool samples, 
allowing comparisons of full or near full (>85%) genome sequences from 4 outbreaks and partial genome com-
parisons in 3 outbreaks. In total, 14 complete and one partial genotype were detected in the 15 samples from the 
6 outbreaks containing a single NoV genotype compared with 10 complete and five partial genotypes detected 
with the STM approach. In addition, additional genotypes (partial or complete) were identified with the NGS 
approach in the two mixed-genotype outbreaks samples (Ob4 and Ob6). STM generated more genotype informa-
tion than NGS in four cases. In these cases, either none or a low number of NoV reads of mapped to the specific 
genotype, however none of the reads mapped to the ORF1 (pol) or ORF2 (cap) genotyping-regions. This showed 
that although the NGS method overall improved the genotyping results, some samples might be challenging due 
to low amounts of available virus RNA in combination with the random distribution of reads obtained. One way 
to reduce this problem would be to allocate a larger sequencing depth for especially samples with low amounts 
of virus.
The NGS derived consensus sequences used for phylogenetic comparison ranged from 1226 to 7692 nt (aver-
age 4800 nt) and included either the complete or a substantial proportion of the hypervariable P2 region. In 
comparison, STM only covers ~9% of the genome and does not include the P2 region. Therefore, even in the 
three outbreaks, in which only partial genomes were recovered, the data were found to significantly improve the 
molecular resolution of outbreaks.
Interestingly, minor nucleotide variations between sequences from different samples from three of the out-
breaks were observed. Two of these differences were mapped to the P2 region, known to be highly variable12, 34–36 
and a single nucleotide difference was observed between two groups of samples from a single epidemiologically 
linked outbreak (Ob-2). This challenge the 100% identity-paradigm used in general NoV outbreak investiga-
tions12, 36 that normally distinguishes only between identical and non-identical strains. Other studies have also 
questioned if these strict criteria should be maintained37, when comparing larger parts of the NoV genome.
NoV bioaccumulation in or adhesion to food items such as oysters and lettuce generates complex outbreak 
profiles including several genotypes38, 39, which require separate RT-PCR amplification steps if STM are used39. In 
this study, six NoV genotypes were identified in samples from two mixed outbreaks, three of which was supported 
by high genomic coverages (66% to 99% of the entire NoV genome). HMM improved the detection of geno-
types by identifying a genotype (GII.Pg_GII.1) missed using STM. Although phylogenetic comparisons could 
not be performed for all genotypes due to varied sequence coverage of some genotypes in the samples, greater 
sequencing depth may circumvent this problem in future analysis. Interestingly, a mutually exclusive presence 
of genotypes was observed for three of the four genotypes identified in the two samples from Ob-4 and different 
relative abundances of the two genotypes found in Ob-6 was found for sample Ob-6-3 compared with the other 
Figure 5. Read mappings for the recombinant NoV strain. (a) Mapping of reads to the reference sequence 
KM036380 (GII.P16_GII.13), (b) Mapping of reads to the reference sequence JX459908 (GII.Pe_GII.4_
Sydney_2012), (c) Analysis of reads spanning the recombination junction region. This was performed by 
constructing an in silico reference sequence composed of pos. 4880 to 5051 of KM036380 joined with pos. 5068 
to 5239 of JX459908 (the junction is marked with a “J”); reads were subsequently mapped to this reference 
sequence to identify junction-spanning reads.
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samples. This could indicate differences in host exposure and/or susceptibility to different NoV genotypes in 
complex outbreaks.
A near-complete genome sequence of (>90%) a new GII.P16_GII.4_Sydney recombinant NoV was directly 
confirmed from the NGS data by using reads spanning the ORF1/ORF2 junction of the two different genotypes, 
showing that NGS can be used to distinguish between co-infection with different genotypes and new emergent 
recombinants.
This study was performed retrospectively on samples stored at −20 °C and previously analyzed by STM where 
samples had all been freeze-thawed at least twice, which may have resulted in some degree of degradation of 
the NoV. Five samples were excluded after poly(A)-capture, as a large increase (>5) in Ct values were observed, 
indicating fragmentation of NoV RNA. Therefore, for future applications of the present method, it will be of great 
importance to retain NoV RNA integrity until library preparation.
We have introduced a novel NoV enrichment NGS-based approach to investigate foodborne outbreaks with-
out discriminating between genotypes. This method can be used directly to enrich other clinically important 
viruses in stool such as enteroviruses, or other positive-sense RNA viruses with a polyadenylated 3′ tail. Although 
the poly (A)-capture lead to a 3′ bias in sequencing depth, it allowed for a significant enrichment of NoV reads 
obtained from the samples. Future studies are required to test the efficiency of enrichment from other specimen 
types. Although the likelihood of obtaining complete NoV genomes is strongly dependent on NoV concentration 
in the sample, deeper sequencing would likely allow for retrieval of more NoV reads even in more scarce NoV 
samples. With common access to benchtop sequencers, we anticipate that NGS will soon become a definitive, 
non-discriminatory tool for viral infection control and serve to monitor both the evolution and spread of geno-
types and enhance viral outbreak investigations.
Materials and Methods
Ethics statement. According to the “Danish Act on Research Ethics Review of Health Research Projects” 
this study does not require approval by the ethics committees, as it is considered a quality development/control 
project and does not analyze human sequences. This was confirmed by the Committees on Health Research Ethics 
for the Capital Region of Denmark in a specific waiver of approval (H-16019654).
Sample material. Twenty-four NoV positive samples from eight different foodborne outbreaks (termed 
Ob1 to Ob8) were analyzed (Table 3). Five survey samples (termed S1 to S5) and 9 quantitative survey samples 
(termed QS1 to QS9) were analyzed with or without poly(A)-capture to assess the efficiency of this method. Five 
samples where Ct values increased >5 after poly(A)-capture vs. before were excluded from NGS analysis as they 
were considered to be too degraded.
Extraction of nucleic acids, poly(A) capture, real-time RT-PCR and norovirus typing. Nucleic 
acids were extracted from 10% stool suspensions (kept at −20 °C) using the MagNA Pure LC (Roche Diagnostics); 
poly(A)-capture was performed using a Dynabeads mRNA Purification Kit (Ambion Cat. No. 61006) according 
to the manufacturer’s instructions with modifications to use 100 µL input material and 26 µL Dynabeads. The con-
centration of nucleic acids was measured using 1 µL extract on a NanoDrop 1000 Spectrophotometer (NanoDrop 
Technologies). The presence of NoV Genogroup I and II was assessed using real-time multiplex PCR40 and geno-
typing was performed as described previously40, 41.
Quantification of NoV RNA. A quantitative NoV GGI standard was obtained from ATCC (Quantitative 
Synthetic Norovirus G1 (I) RNA (ATCC® VR3234SD™; specification range (log10) 5–6 RNA copies/µL, of which 
the lower end range was used for the calculations. In addition, a previously published NoV GGII standard42 was 
obtained from collaborators at the Danish Technical University at a confirmed concentration of 5.19 (log10) ± 4.80 
(log10) RNA copies/µL. Both standards were diluted in a fivefold 1:10 dilution series and analyzed in triplicates 
in the real time multiplex PCR (described above) alongside 9 NoV Quantiative Survey samples (QS1 to QS9; all 
both with and without poly(A)-capture). Analysis of real time data was performed in MxPro Mx3005 P v4.10, 
Outbreak 
(Ob) Month and year
Suspected mode 
of transmission
Samples 
analyzed 
with NGS
Ob-1 March 2013 Person to person Five
Ob-2 December 2013 Person to person Two
Ob-3 February 2014 Person to person Two
Ob-4 March 2014 Oysters Two
Ob-5 June 2014 Person to person Two
Ob-6 January 2015
Unknown (oysters 
or person to 
person)
Seven
Ob-7 April 2015 Unknown (fruit suspected) Two
Ob-8 July 2015 Person to person Two
Table 3. Line-list of eight norovirus-associated outbreaks in Denmark 2013–2015. Legend: Column 1: 
Outbreak number in chronological order, Column 2: Month and year of the outbreak, Column 3: Suspected 
mode of transmission, Column 4: Number of samples analyzed with NGS.
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resulting in the following standard curves for GGI and GGII respectively: Y = −3.047xLOG(X) + 41.74; R2: 0.994 
and Y = −3.090xLOG(X) + 41.18; R2: 0.971. Calculations of the amount of NoV genomes used as input in the 
extraction/capture and NGS analyses were also performed in MxPro.
Preparation of samples for Illumina MiSeq sequencing. Single-indexed cDNA libraries were gener-
ated using the SMARTer Stranded RNA-Seq Kit (Clontech Inc.) in accordance with the manufacturer’s instruc-
tions. Fluorescent measurement of DNA concentrations in each library was performed using Qubit dsDNA BR 
and ssDNA assay kit (Thermo Fischer Scientific).
Quality trimming and filtering. Sequences were imported into CLCbio’s Genomics Workbench (v. 8.5) 
with the removal of failed reads. Quality trimming within the workbench was performed using both a modified 
Mott trimming algorithm implemented (limit = 0.5) and by trimming reads containing more than two ambigu-
ous nucleotides. Human sequence reads were removed by alignment to the homo sapiens hg19 reference genome 
(similarity fraction = 0.8).
Reference based mapping. Quality-trimmed reads were mapped to reference sequences using the 
Mapping tool in CLCbio’s Genomics Workbench with default settings. NoV reads from all samples loaded on 
the same MiSeq run were mapped to all expected reference sequences. The following reference sequences were 
used for mapping of Miseq reads: JQ388274 (GI.Pb_GI.6), JX459908 (GII.Pe_GII.4_Sydney), KJ685411 (GII.
P4_New_Orleans_GII.4_Sydney), DQ456824 (GII.P2_GII.2), EU921389 (GII.P21_GII.3), HCU07611 (GII.
Pg_GII.1), JQ388274 (GI.Pb_GI.6), KJ196292.1 (GI.P3_GI.3), KM198484 (GII.P21_GII.3), KM198534 (GII.
P7_GII.6) and the following reference sequences were used in the phylogenetic analysis: AB187514.1 (GI.P3_
GI.3), KM198484 (GII.P21_GII.3), KM198500.1 (GII.P21_GII.3), EU921389 (GII.P21_GII.3), KJ685411 (GII.
P4_New_Orleans_2009_GII.4_Sydney_2012), JX459908 (GII.Pe_GII.4_Sydney), LN854568 (GII.P7_GII.6), 
JQ388274 (GI.Pb_GI.6), LN854564.1 (GI.Pb_GI.6), KM036380 (GII.P16_GII.13), JX459908 (GII.Pe_GII.4_
Sydney). In cases where no appropriate full-length reference sequence was available for mapping of reads, a de 
novo assembled sequence (see below) or a consensus sequence generated from the most similar full-length refer-
ence sequence available was used instead.
De novo assembly. Reads from three outbreaks (Ob-1, Ob-6 and Ob-8) were mapped to de novo assem-
bled reference sequences, as no well-matching and/or full-length reference sequences were identified in public 
databases. De novo assembled reads were generated using CLCbio’s assembler at default settings and with the fast 
mapping mode and a minimum contig length of 200 bases.
Generation of consensus sequences. Consensus sequences were generated from mapped reads using 
the majority vote option and inserting N in places of ambiguity or missing data. Depth thresholds at >0, >2, or 
≥5 reads were evaluated for sequence quality, and only high quality consensus sequences (average quality score 
≥30, as calculated in CLCbio) were used for sequence comparison and phylogenetic analysis. The P2 region on 
the consensus sequence was defined as previously described11.
Confirmation of genotypes. Genotypes from all mappings were confirmed by submission of consensus 
sequences to analysis at the Dutch National Institute for Public Health and the Environment (RIVM)’s NoV 
typing tool (http://www.rivm.nl/mpf/norovirus/typingtool) and/or BLASTN followed by genotyping of the best 
hits at RIVM.
Hidden Markov model (HMM) building and searches. In total, 858 sequences matching the terms 
“norovirus” and “complete” at NCBI (accessed on April 25th, 2015) were downloaded and genotypes confirmed 
using the Dutch National Institute for Public Health and the Environment (RIVM)’s NoV typing tool (http://
www.rivm.nl/mpf/norovirus/typingtool). From this set, 112 representative sequences were selected for hidden 
Markov model (HMM) building. Sequences were aligned in MAFFT v.7 (http://www.ebi.ac.uk/Tools/msa/mafft/) 
and a NoV HMM was built using HMMer 3.043. HMM searches were performed among de novo assembled reads 
at default settings and identified assemblies evaluated by BLASTN and NoV typing at RIVM.
Multiple alignment and phylogenetic analyses. Consensus and reference sequences were aligned in 
MAFFT and phylogenetic analyses were performed by maximum-likelihood with a generalized time-reversible 
(GTR) substitution model and a 1000 bootstrap replicates in MEGA 6.0644.
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